Potential clinical utility of liquid biopsy in early|stage non|small cell ...

Potential clinical utility of liquid biopsy in early-stage non-small cell ...

Liquid biopsy has been widely researched for early diagnosis, prognostication and disease monitoring in lung cancer, but there is a need to ...

Potential clinical utility of liquid biopsy in early-stage non-small cell ...

In conclusion, our study indicated liquid biopsy could reliably facilitate more precision and effective management of early-stage NSCLC.

Liquid biopsy in detecting early non-small cell lung cancer

The characterization of circulating tumor cells (CTCs) and cell-free DNA constitutes two key components of liquid biopsies' applicability [12,15]. Recent ...

Clinical Utility and Application of Liquid Biopsy Genotyping in Lung ...

Precision medicine has revolutionized the therapeutic management of cancer patients with a major impact on non-small cell lung cancer ...

Clinical utility of liquid biopsy and integrative genomic profiling in ...

Many studies have shown a good correlation between tissue and liquid biopsies in advanced-stage patients [22,23,24,25,26,27]. However, in cases ...

Current and future applications of liquid biopsy in non-small-cell ...

In metastatic NSCLC, ctDNA testing already plays a vital role in clinical practice, allowing the detection of tumor-derived somatic aberrations from plasma to ...

Clinical utility of liquid biopsy-based companion diagnostics in the ...

The next stage of implementation of liquid biopsy for routine clinical settings is for monitoring of ctDNA after surgical treatment to predict ...

Clinical application of liquid biopsy based on circulating tumor DNA ...

Early detection of abnormal cancer molecules and subsequent personalized treatment plans are the most effective ways to address this problem. Liquid biopsy, ...

Liquid Biopsy in Early-Stage Lung Cancer: Current and Future ...

This review aims to present the current evidence on clinical applications of liquid biopsies in early-stage non-small cell lung cancer and highlight ...

Exploring the clinical utility of liquid biopsy with cfDNA in cancer

Throughout this review, we interchangeably referred to cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) in the context of screening cancer patient ...

Liquid biopsy for therapy monitoring in early-stage non-small cell ...

Liquid biopsy has been incorporated in clinical practice as a valuable diagnostic tool for advanced metastatic non-small cell lung cancer (NSCLC) ...

Liquid biopsy for lung cancer early detection - Santarpia

Liquid biopsy has recently demonstrated its clinical usefulness in advanced NSCLC as a surrogate of tissue biopsy for noninvasive assessment of specific ...

An overview of current development and barriers on liquid biopsy in ...

Liquid biopsy is a promising technological method in patient management of early-stage non-small-cell lung cancer (NSCLC).

What's Driving, and Blocking the Liquid Biopsy Evolution in Non ...

... small cell lung cancer as the utility of liquid biopsies in the detection of key biomarkers continues to be confirmed through clinical trials.

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From ...

The liquid biopsy approach includes a variety of methodologies for circulating analytes. From a clinical point of view, plasma circulating tumor ...

(PDF) Potential clinical utility of liquid biopsy in early-stage non ...

PDF | Abstract Background Liquid biopsy has been widely researched for early diagnosis, prognostication and disease monitoring in lung cancer, but there.

Circulating tumor DNA to guide diagnosis and treatment of localized ...

Therefore, numerous clinical applications of ctDNA in the management of early-stage lung cancer are emerging, such as lung cancer screening, the identification ...

Potential clinical utility of liquid biopsy in early-stage non-small cell ...

Abstract Background Liquid biopsy has been widely researched for early diagnosis, prognostication and disease monitoring in lung cancer, but there is a need ...

Liquid biopsy and non-small cell lung cancer: are we looking at the ...

Notably, their analytical specificity reaches 98% [39,40,41]. Anyway, even though the detection of EGFR mutations in ctDNA is possible even at ...

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

Liquid biopsy is a non-invasive, easy and accessible tool for tumor cells or tumor-derived products detection in body fluids, with the potential of overcome the ...